IGIL.NS(IGIL.NS)
IGIL.NS
No analyst ratings available
No analyst price targets available for IGIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $14.34B | $16.19B | $19.05B | $19.36B |
| Low | $14.26B | $15.96B | $18.85B | $19.16B |
| High | $14.42B | $16.41B | $19.24B | $19.55B |
| EBITDA Avg | $9.20B | $10.38B | $12.22B | $12.42B |
| Low | $9.15B | $10.24B | $12.09B | $12.29B |
| High | $9.25B | $10.52B | $12.34B | $12.54B |
| EBIT Avg | $8.68B | $9.80B | $11.53B | $11.72B |
| Low | $8.63B | $9.67B | $11.42B | $11.60B |
| High | $8.74B | $9.94B | $11.65B | $11.84B |
| Net Income Avg | $6.56B | $7.66B | $9.47B | $10.27B |
| Low | $6.53B | $7.31B | $8.98B | $10.14B |
| High | $6.70B | $7.87B | $9.95B | $10.41B |
| EPS Avg | $14.75 | $16.93 | $21.10 | $22.90 |
| Low | $14.55 | $16.30 | $20.01 | $22.60 |
| High | $14.94 | $17.55 | $22.19 | $23.20 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $4.33B | $4.69B |
| Low | $4.33B | $4.69B |
| High | $4.33B | $4.69B |
| EBITDA Avg | $2.78B | $3.01B |
| Low | $2.78B | $3.01B |
| High | $2.78B | $3.01B |
| EBIT Avg | $2.62B | $2.84B |
| Low | $2.62B | $2.84B |
| High | $2.62B | $2.84B |
| Net Income Avg | $1.41B | $1.57B |
| Low | $1.41B | $1.57B |
| High | $1.41B | $1.57B |
| EPS Avg | $3.15 | $3.52 |
| Low | $3.15 | $3.52 |
| High | $3.15 | $3.52 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 1 |